Top Markets
#1 QuantixAI QuantixAI +102.94%
#2 Pons Pons +35.47%
#3 龙虾 (Lobster) 龙虾 (Lobster) +30.81%
#4 Rain Rain +30.63%
#5 MetaDAO MetaDAO +27.10%
#6 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.74%
#7 Bedrock Bedrock +20.16%
#8 Prom Prom +17.45%
#9 Ontology Gas Ontology Gas +15.41%
#10 peaq peaq +15.03%
Coin of the day
QuantixAI QuantixAI
Settings
Language
ENGLISH
Currency
USD
Theme
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Rank in Stocks #2605
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Share Price
$27.75
Market Cap
$7.84B
Change (1 day)
6.21%
Change (1 year)
-27.88%
Country
US
Trade Caris Life Sciences, Inc. (CAI)

Category

Healthcare
Earnings for Caris Life Sciences, Inc. (CAI)
Earnings in 2026 TTM: 0
According to Caris Life Sciences, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Caris Life Sciences, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH